Your session is about to expire
← Back to Search
Prebiotics for Multiple Myeloma
Study Summary
This trial will test whether prebiotic supplementation with resistant starch can improve gut microbiome diversity at time of stem cell engraftment in patients with myeloma or lymphoma.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I am 19 years old or older.I have had weight loss surgery or suffer from a long-term gut condition.You had a bad reaction to taking fiber supplements before.I have been diagnosed with multiple myeloma, Non-Hodgkin lymphoma, or Hodgkin lymphoma.I am unwilling to provide stool samples for the study.I am recommended for my first stem cell transplant using my own cells.I am eligible for a stem cell transplant as per my doctor's advice.You are allergic to potato starch or maltodextrin.
- Group 1: Treatment
- Group 2: Placebo
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
How many individuals are being evaluated in this clinical trial?
"The clinical trial is, as of now, looking for enrollees. The study was first made public on 4/13/2022 and was updated on 4/14/2022. They are currently 30 spots available at 1 location."
Are there any openings in this trial for new participants?
"That is accurate, the website clinicaltrials.gov has information suggesting that this study is recruiting patients as we speak. This trial was first posted on April 13th, 2022 and was updated on the 14th of the same month. They are looking for a total of 30 individuals across 1 site."
What are we trying to learn from this clinical trial?
"The main aim of this study, which will be measured over a period of 35 days, is to see how well participants stick to the scheduled doses of the intervention. Other outcomes that will be looked at include hospital stay (defined as the time from stem cell transplant to discharge), rate of neutropenic fever (a type of fever that can occur after a stem cell transplant), and rate of gastrointestinal symptoms."
Share this study with friends
Copy Link
Messenger